Free Trial

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives $17.60 Average Price Target from Analysts

Crescent Capital BDC logo with Finance background

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $17.60.

A number of analysts have recently issued reports on CCAP shares. Wall Street Zen lowered shares of Crescent Capital BDC from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Wells Fargo & Company cut their target price on shares of Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, May 16th. Keefe, Bruyette & Woods downgraded shares of Crescent Capital BDC from an "outperform" rating to a "market perform" rating and decreased their target price for the stock from $18.50 to $17.00 in a research report on Friday, May 16th. Finally, Raymond James reduced their target price on Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating for the company in a report on Friday, May 16th.

View Our Latest Analysis on CCAP

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of CCAP. Condor Capital Management increased its stake in shares of Crescent Capital BDC by 3.3% during the 1st quarter. Condor Capital Management now owns 293,289 shares of the company's stock worth $5,021,000 after purchasing an additional 9,234 shares during the last quarter. Franklin Resources Inc. raised its stake in Crescent Capital BDC by 12.8% in the fourth quarter. Franklin Resources Inc. now owns 289,131 shares of the company's stock valued at $5,557,000 after buying an additional 32,852 shares during the period. Wells Fargo & Company MN lifted its position in shares of Crescent Capital BDC by 0.5% in the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company's stock valued at $4,866,000 after buying an additional 1,210 shares during the last quarter. Raymond James Financial Inc. boosted its stake in shares of Crescent Capital BDC by 7.8% during the 1st quarter. Raymond James Financial Inc. now owns 210,285 shares of the company's stock worth $3,600,000 after acquiring an additional 15,155 shares during the period. Finally, Kovitz Investment Group Partners LLC increased its holdings in shares of Crescent Capital BDC by 14.4% during the 1st quarter. Kovitz Investment Group Partners LLC now owns 202,873 shares of the company's stock worth $3,473,000 after acquiring an additional 25,528 shares during the last quarter. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Stock Performance

CCAP traded up $0.13 during trading on Thursday, reaching $15.52. 76,481 shares of the company were exchanged, compared to its average volume of 139,239. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. Crescent Capital BDC has a 52 week low of $13.54 and a 52 week high of $20.19. The firm has a 50 day moving average of $15.98 and a 200 day moving average of $17.97. The stock has a market cap of $575.17 million, a P/E ratio of 7.80 and a beta of 0.63.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.52 by ($0.07). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The firm had revenue of $42.13 million during the quarter, compared to analyst estimates of $45.08 million. On average, sell-side analysts forecast that Crescent Capital BDC will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Monday, June 30th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 10.82%. The ex-dividend date of this dividend is Monday, June 30th. Crescent Capital BDC's dividend payout ratio (DPR) is currently 125.37%.

About Crescent Capital BDC

(Get Free Report

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines